Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;7(3):207-208.
doi: 10.1016/j.jegh.2017.05.003. Epub 2017 May 24.

Frequency and implications of ofloxacin resistance among previously treated tuberculosis patients

Jyoti Arora  1 , Gavish Kumar  1 , Ajoy Kumar Verma  1 , Manpreet Bhalla  1 , Ritu Singhal  1 , Rohit Sarin  2 , Vithal Prasad Myneedu  3
Affiliations

Frequency and implications of ofloxacin resistance among previously treated tuberculosis patients

Jyoti Arora et al. J Epidemiol Glob Health. 2017 Sep.
No abstract available

Keywords: Drug resistance; Fluoroquinolones; Multi drug resistant; Ofloxacin; Previously treated.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Migliori GB, Langendam MW, D’Ambrosio L, Centis R, Blasi F, Huitric E, et al. Protecting the TB drug pipeline. Stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012;48(1):814–22. doi: 10.1183/09031936.00036812. - DOI - PMC - PubMed
    1. Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, et al. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest J. 2000;117(3):744–51. doi: 10.1378/chest.117.3.744. - DOI - PubMed
    1. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, et al. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis. 2009;13(9):1154–60. - PubMed
    1. Verma JS, Nair D, Rawat D, Manzoor N. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis. Indian J Med Microbiol. 2011;29(3):280–2. doi: 10.4103/0255-0857.83913. - DOI - PubMed
    1. Jain A, Dixit P, Prasad R. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates. Tuberculosis. 2012;92(5):404–6. doi: 10.1016/j.tube.2012.05.010. - DOI - PubMed